Home > PB Ratio > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
PB (Price/Book ) Ratio

The Current P/B Ratio of ONESOURCE SPECIALTY PHARMA is 2.09.

Share Price ₹1,587.4Apr 02,2025
Market Cap ₹18,159.3 Cr
Book Value₹8,695.7 CrMar2024 - Standalone Results
Price/Book 2.09xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of ONESOURCE SPECIALTY PHARMA

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of ONESOURCE SPECIALTY PHARMA is calculated as :

Current Market Cap [ ₹18,159.3 Cr] as on Apr 02,2025

(/) Book Value [ ₹8,695.7 Cr] based on Mar2024 - Standalone Results

(=) P/B Ratio [ 2.09x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '2.09 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of ONESOURCE SPECIALTY PHARMA !

The chart below summarizes the trend in P/B Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.

Historical PB (Price/Book ) ratio chart of ONESOURCE SPECIALTY PHARMA


PB Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA

- ONESOURCE SPECIALTY PHARMA 's latest p/b ratio is 2.09x.

- ONESOURCE SPECIALTY PHARMA 's p/b ratio for fiscal years ending to Apr 02,2025 averaged nanx.

- ONESOURCE SPECIALTY PHARMA 's operated at median p/b ratio of x from fiscal years ending March 2018 to 2022.

- Looking back at the last 0 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/b ratio peaked in at x.

- ONESOURCE SPECIALTY PHARMA 's p/b ratio hit its five-year low in of x.


How does ONESOURCE SPECIALTY PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
ONESOURCE SPECIALTY PHARMA 8,695.702.0918,159.3
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.46411,306.0
DIVIS LABORATORIES LTD13,571.0011.08150,343.0
CIPLA LTD26,619.904.41117,323.0
TORRENT PHARMACEUTICALS LTD6,856.1515.84108,619.0
DR REDDYS LABORATORIES LTD28,123.503.4195,941.5
MANKIND PHARMA LTD9,339.8410.7099,891.5
ZYDUS LIFESCIENCES LTD19,829.504.5289,680.6
LUPIN LTD14,175.806.4791,742.2
AUROBINDO PHARMA LTD29,842.802.2567,294.6
ABBOTT INDIA LTD3,658.7317.1862,839.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs ONESOURCE SPECIALTY PHARMA 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.09x
Max industry PB 17.18x
Median industry PB 6.46x
Average industry PB 7.67x



You may also like the below Video Courses